Skip to content
DataLookout
Menu

CORDSTIM-VLUNCT07449988

Modified Platform Trial Assessing Multiple Umbilical Cord-based CAMPs and SOC v SOC Alone in the Treatment of Hard-to-Heal VLUs

StatusNot Yet Recruiting
PhaseNot applicable
SponsorStimLabs
Primary completion (estimated)

At risk: Primary completion moved at least 4 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

Version history last read from ClinicalTrials.gov on Aug 30, 2026. The record was updated there on Nov 20, 2026; versions filed since then are not listed here yet.

All 1 version: 1 with changes below. See every version on ClinicalTrials.gov ↗

  1. Minor Primary completion pushed from Jul 2029 to Dec 2029
    • Study completion pushed from Sep 2029 to Apr 2030
  2. Study First Submitted
  • Minor: routine updates

Endpoints

Primary

The percentage of target ulcers achieving complete wound closure
Timeframe: 1-12 weeks
Adverse events
Timeframe: 1-14 weeks

Secondary (5)

Time to closure for the target ulcer
Percent area reduction
Change in pain in target ulcer
Determine improvement in Quality of Life - wQOL
Determine improvement in Quality of Life - FWS

Arms and interventions

Standard of CareActive comparator

Standard of care will be cleaning, debridement, ulcer moisture balance, and compression therapy.

Corplex P (and alternate brand names Allacor P and Theracor P)Experimental

Corplex P (and alternate brand names Allacor P and Theracor P) is a dehydrated human umbilical cord-based particulate device.

TheracorExperimental

Theracor is a dehydrated human umbilical cord-based sheet device.

Other: Standard of Care (SOC)

Devices: Corplex P, Theracor